3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Lymphoma
8
Leukemia, Myeloid, Acute
7
Neutropenia
5
Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Leukemia, Monocytic, Acute
3
Leukemia, Biphenotypic, Acute
3
Uterine Cervical Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Osteosarcoma
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Chronic
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Thoracic Neoplasms
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma, Myeloid
1
Sarcoma, Clear Cell
1
Rhabdoid Tumor
1
Retinoblastoma
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Interventions
Filgrastim
10
Cyclophosphamide
8
Granulocyte Colony-Stimulating Factor
6
Melphalan
5
Busulfan
5
Vincristine
4
Topotecan
4
Temozolomide
4
Stem Cell Transplantation
4
Peripheral Blood Stem Cell Transplantation
4
Ifosfamide
4
Etoposide
4
Thiotepa
3
Radiotherapy
3
Mesna
3
Itraconazole
3
Doxorubicin
3
Cisplatin
3
Carboplatin
3
sargramostim
2
fludarabine
2
Therapeutics
2
Sirolimus
2
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
Drug Therapy
2
Bone Marrow Transplantation
2
Blood Specimen Collection
2
Amplified Fragment Length Polymorphism Analysis
2
trioctyl phosphine oxide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Wilms Tumor
×
pegylated granulocyte colony-stimulating factor
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled